MRM Health and IFF Reach Second Milestone in the Partnered … – Business Wire
GHENT, Belgium–(BUSINESS WIRE)–MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics—today announced that its Type-2 Diabetes Program, developed in collaboration with IFF (NYSE: IFF) has achieved…